Reporting Manager
Point72 Asset Management, L.P.
Symbol
PLRX
Disclosed Ownership
46,537 shares
Ownership
0.1%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:29:00 UTC
Date of event
31 Dec 2025
Previous filing
04 Sep 2025

Sponsored

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 0.1% ownership in PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (PLRX) on 31 Dec 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G/A for PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (PLRX).
  • Disclosed ownership: 0.1%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 04 Sep 2025.
  • Current filing was accepted on 17 Feb 2026, 16:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 0.1% 46,537 0 46,537 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 0.1% 46,537 0 46,537 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 0.1% 46,537 0 46,537 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person